Pasar al contenido principal

SEÑALIZACION POR CA2+: UNA NUEVA DIANA PARA ACTUAR SOBRE EL ENVEJECIMIENTO Y LAS ENFERMEDADES NEURODEGENERATIVAS

PID2021-122239OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE VALLADOLID

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Arrhythmic Effects Evaluated on Caenorhabditis elegans, The Case of Polypyrrole Nanoparticles

  • Srinivasan, Sumithra Yasaswini|||0000-0002-0473-9801
  • Illera, Pilar Alvarez
  • Kukhtar, Dmytro
  • Benseny Cases, Núria|||0000-0003-4603-6829
  • Cerón, Julián|||0000-0003-4739-2243
  • Álvarez, Javier
  • Fonteriz, Rosalba I.
  • Montero, Mayte
  • Laromaine, Anna|||0000-0002-4764-0780
Experimental studies and clinical trials of nanoparticles for treating diseases are increasing continuously. However, the reach to the market does not correlate with these efforts due to the enormous cost, several years of development, and off-target effects like cardiotoxicity. Multicellular organisms such as the Caenorhabditis elegans (C. elegans) can bridge the gap between in vitro and vertebrate testing as they can provide extensive information on systemic toxicity and specific harmful effects through facile experimentation following 3R EU directives on animal use. Since the nematodes' pharynx shares similarities with the human heart, we assessed the general and pharyngeal effects of drugs and polypyrrole nanoparticles (Ppy NPs) using C. elegans. The evaluation of FDA-approved drugs, such as Propranolol and Racepinephrine reproduced the arrhythmic behavior reported in humans and supported the use of this small animal model. Consequently, Ppy NPs were evaluated due to their research interest in cardiac arrhythmia treatments. The NPs' biocompatibility was confirmed by assessing survival, growth and development, reproduction, and transgenerational toxicity in C. elegans. Interestingly, the NPs increased the pharyngeal pumping rate of C. elegans in two slow-pumping mutant strains, JD21 and DA464. Moreover, the NPs increased the pumping rate over time, which sustained up to a day post-excretion. By measuring pharyngeal calcium levels, we found that the impact of Ppy NPs on the pumping rate could be mediated through calcium signaling. Thus, evaluating arrhythmic effects in C. elegans offers a simple system to test drugs and nanoparticles, as elucidated through Ppy NPs.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

SERCA inhibition improves lifespan and healthspan in a chemical model of Parkinson disease in Caenorhabditis elegans

  • Romero-Sanz, Silvia
  • Caldero-Escudero, Elena
  • Alvarez-Illera, Pilar
  • Santo-Domingo, Jaime
  • Fonteriz, Rosalba I.
  • Montero, Mayte
  • Álvarez, Javier
[Introduction]: The high prevalence of neurodegenerative diseases in our population and the lack of effective treatments encourage the search for new therapeutic targets for these pathologies. We have recently described that submaximal inhibition of the Sarco-Endoplasmic Reticulum Ca2+ ATPase (SERCA), the main responsible for ER calcium storage, is able to increase lifespan in Caenorhabditis elegans worms by mechanisms involving mitochondrial metabolism and nutrient-sensitive pathways. [Methods]: We have studied here the effects of submaximal SERCA inhibition in a chemical model of Parkinson’s disease (PD) induced in C. elegans worms by treatment with the mitochondrial complex I inhibitor rotenone. For specific SERCA inhibition, we treated worms with RNAi against sca-1, the sole orthologue of SERCA in C. elegans. [Results and Discussion]: Our results show that rotenone produces alterations in worms that include decreased lifespan, smaller size, reduced fertility, decreased motility, defecation and pumping rate, increased mitochondrial ROS production, reduced mitochondrial membrane potential and oxygen consumption rate, altered mitochondrial structure, and altered ethanol preference in behavioral studies. Most of these alterations were either fully or partially reversed in worms treated with sca-1 RNAi, suggesting that SERCA inhibition could be a novel pharmacological target in the prevention or treatment of neurodegeneration., This research was funded by grants from the Spanish Ministerio de Ciencia e Innovación to MM and JÁ (BFU 2017-83509-R and PID 2021-122239OB-I00, co-financed by the European Union through the European Regional Development Fund). SR-S and EC-E both have a fellowship from the University of Valladolid., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Arrhythmic Effects Evaluated on Caenorhabditis elegans: The Case of Polypyrrole Nanoparticles

  • Srinivasan, Sumithra Y.
  • Alvarez-Illera, Pilar
  • Kukhtar, Dmytro
  • Benseny-Cases, Núria
  • Cerón, Julián
  • Álvarez. Javier
  • Fonteriz, Rosalba I.
  • Montero, Mayte
  • Laromaine, Anna
Experimental studies and clinical trials of nanoparticles for treating diseases are increasing continuously. However, the reach to the market does not correlate with these efforts due to the enormous cost, several years of development, and off-target effects like cardiotoxicity. Multicellular organisms such as the Caenorhabditis elegans (C. elegans) can bridge the gap between in vitro and vertebrate testing as they can provide extensive information on systemic toxicity and specific harmful effects through facile experimentation following 3R EU directives on animal use. Since the nematodes’ pharynx shares similarities with the human heart, we assessed the general and pharyngeal effects of drugs and polypyrrole nanoparticles (Ppy NPs) using C. elegans. The evaluation of FDA-approved drugs, such as Propranolol and Racepinephrine reproduced the arrhythmic behavior reported in humans and supported the use of this small animal model. Consequently, Ppy NPs were evaluated due to their research interest in cardiac arrhythmia treatments. The NPs’ biocompatibility was confirmed by assessing survival, growth and development, reproduction, and transgenerational toxicity in C. elegans. Interestingly, the NPs increased the pharyngeal pumping rate of C. elegans in two slow-pumping mutant strains, JD21 and DA464. Moreover, the NPs increased the pumping rate over time, which sustained up to a day post-excretion. By measuring pharyngeal calcium levels, we found that the impact of Ppy NPs on the pumping rate could be mediated through calcium signaling. Thus, evaluating arrhythmic effects in C. elegans offers a simple system to test drugs and nanoparticles, as elucidated through Ppy NPs., This work was supported by the Ministry of Science and Innovation (MICINN) “Severo Ochoa” program for centers of excellence through the BEAT project (FUNFUTURE-FIP-2020), MICINN project PID2021-122239OB-I00 and partly supported by the European Union’s Horizon Europe research and innovation program under grant agreement No 101057527 (NextGEM). Funded by the European Union. Some experiments were performed at MIRAS beamline at ALBA Synchrotron with the collaboration of ALBA staff. SYS is enrolled in the Materials Science Ph.D. program of Universitat Autonoma de Barcelona (UAB). SYS acknowledges financial support from DOC-FAM, European Union’s Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant agreement No 754397. AL and SYS participate in the networks of EPNOE, Red Nanocare2.0 , and the CSIC Interdisciplinary Platform for Sustainable Plastics toward a Circular Economy, SUSPLAST. The authors acknowledge the use of Biorender.com, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Calreticulin (crt-1) silencing reduces Aß1–42-induced toxicity and restores muscle function in C. elegans.

  • Caldero-Escudero, Elena
  • Romero-Sanz, Silvia
  • Alvarez-Illera, Pilar
  • Fuente, Sergio de la
  • García-Casas, Paloma
  • Fonteriz, Rosalba I.
  • Montero, Mayte
  • Álvarez, Javier
  • Santo-Domingo, Jaime
Accumulation of aggregated β-amyloid peptide is a key histopathological feature of Alzheimer's Disease (AD). Experimental models of AD based on β-amyloid peptide display calcium (Ca2+) signaling alterations, and targeting key components of the cellular Ca2+ signaling system has been postulated to modulate AD onset and progression. Here we have taken advantage of a C. elegans strain that over-expresses the most toxic human ß-amyloid peptide (Aß1–42) in body-wall muscle cells, to study the impact of calreticulin (crt-1) silencing on body-wall muscle performance. Crt-1 knockdown reduced the percentage of paralyzed worms in a dose-dependent manner and improved locomotion parameters in free-mobility assays in Aß1–42-overexpressing worms. At the cellular level, crt-1 silencing prevented Aß1–42-induced exacerbated mitochondrial respiration and mitochondrial ROS production without impacting mitochondrial sarcomere organization. Crt-1 knockdown reduced the number and size of Aß1–42 aggregates in body-wall muscle cells and prevented the formation of Aß1–42 oligomers. We propose that crt-1 depletion reduces the number of Aß1–42 aggregates, precluding Aß1–42-induced mitochondrial toxicity and improving muscle function. We identify C. elegans crt-1 as a gene involved in the toxicity associated with the expression of human Aß1–42, and thus a potential new target for treatment., This work was supported by a grant from the Spanish Ministerio de Ciencia e Innovación [Ref. PID2021-122239OB-I00, co-financed by the European Union through the European Regional Development Fund]; Junta de Castilla y Leon (Spain) [Ref. CL-EI-2021]; the University of Valladolid [POSTDOC SEN-2019 UVA27]. S.R.-S. and E.C.-E. have a fellowship from the University of Valladolid. P.G.-C. has a Margarita Salas contract., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Rescue of a Rotenone Model of Parkinson’s Disease in C. elegans by the Mitochondrial Na+/Ca2+ Exchanger Inhibitor CGP37157

  • Romero-Sanz, Silvia
  • Caldero-Escudero, Elena
  • Alvarez-Illera, Pilar
  • Santo-Domingo, Jaime
  • Fuente, Sergio de la
  • García-Casas, Paloma
  • Fonteriz, Rosalba I.
  • Montero, Mayte
  • Álvarez, Javier
We have previously shown that the compound CGP37157, a mitochondrial Na+/Ca2+ exchanger inhibitor, increases lifespan and improves muscle and mitochondrial structure during aging in wild-type C. elegans nematodes. We used here a rotenone model of Parkinson’s disease in C. elegans to test the ability of CGP37157 to rescue the alterations induced by the toxicant. Rotenone, a mitochondrial respiratory chain complex I inhibitor, reduced worm lifespan and muscle activity, measured as worm mobility, pharyngeal pumping, and defecation rate. It also increased ROS production, decreased mitochondrial membrane potential, and disorganized mitochondrial structure. Moreover, it induced degeneration of dopaminergic neurons and changes in behavior. We found that CGP37157 produced a partial or complete reversal of most of these alterations. These results are consistent with our previous proposal that Ca2+ homeostasis is important in the development of neurodegenerative diseases, and modulation of the Ca2+ signaling toolkit may be a novel target for their treatment., This research was funded by a grant from the Spanish Ministerio de Ciencia e Innovación to M.M. and J.Á. (PID2021-122239OB-I00, co-financed by the European Union through the European Regional Development Fund). S.R.-S. and E.C.-E. have a fellowship from the University of Valladolid. P.G.-C. has a Margarita Salas contract., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

SERCA Silencing Alleviates Aß(1-42)-Induced Toxicity in a C. elegans Model

  • Caldero-Escudero, Elena
  • Romero-Sanz, Silvia
  • Alvarez-Illera, Pilar
  • Fernandez-Martinez, Silvia
  • Fuente, Sergio de la
  • García-Casas, Paloma
  • Fonteriz, Rosalba I.
  • Montero, Mayte
  • Álvarez, Javier
  • Santo-Domingo, Jaime
The Sarco Endoplasmic Reticulum Ca2+-ATPase (SERCA) pumps cytosolic Ca2+ into the endoplasmic reticulum lumen (ER) to maintain cytosolic and ER Ca2+ levels under physiological conditions. Previous reports suggest that cellular Ca2+ homeostasis is compromised in Alzheimer’s Disease (AD) and that SERCA activity can modulate the phenotype of AD mouse models. Here, we used a C. elegans strain that overexpresses the most toxic human ß-amyloid peptide (Aß(1-42)) in body-wall muscle cells to study the effects of SERCA (sca-1) silencing on Aß(1-42)-induced body-wall muscle dysfunction. sca-1 knockdown reduced the percentage of paralyzed worms, improved locomotion in free-mobility assays, and restored pharynx pumping in Aß(1-42)-overexpressing worms. At the cellular level, sca-1 silencing partially prevented Aß(1-42)-induced exacerbated mitochondrial respiration and mitochondrial ROS production and restored mitochondrial organization around sarcomeres. sca-1 knockdown reduced the number and size of Aß(1-42) aggregates in body–wall muscle cells and prevented the formation of Aß(1-42) oligomers. Aß(1-42) expression induced a slower kinetics of spontaneous cytosolic Ca2+ transients in muscle cells and sca-1 partially restored these changes. We propose that partial sca-1 loss of function prevents the toxicity associated with beta-amyloid accumulation by reducing the formation of Aß(1-42) oligomers and improving mitochondrial function, in a mechanism that requires remodeling of cytosolic Ca2+ dynamics and partial ER Ca2+ depletion., This work was supported by a grant from the Spanish Ministerio de Ciencia e Innovación [Ref. PID2021-122239OB-I00, co-financed by the European Union through the European Regional Development Fund]; Junta de Castilla y Leon (Spain) [Ref. CL-EI-2021]; the University of Valladolid [POSTDOC SEN-2019 UVA27]. S.R.-S. and E.C.-E. have a fellowship from the University of Valladolid., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Mitochondrial redox homeostasis links organellar stress surveillance to germline and somatic integrity in Caenorhabditis elegans

  • Valenzuela-Villatoro, Marina
  • de la Cruz-Ruiz, Patricia
  • Guerrero-Gómez, David
  • Gómez-Orte, Eva
  • Schiavi, Alfonso
  • Maglioni, Silvia
  • Montero, Mayte
  • Fonteriz, Rosalba I
  • Casas-Martínez, José C.
  • Briand, Nicole E
  • Xu, Jingxiu
  • Rodríguez-Palero, María Jesús
  • Artal-Sanz, Marta
  • Olek, Katarzyna
  • Polaczyk, Justyna
  • Turek, Michal
  • Pokrzywa, Wojciech
  • Xu, Suhong
  • Irazoqui, Javier E
  • McDonagh, Brian
  • Álvarez, Javier
  • Olmedo, María
  • Ventura, Natascia
  • Cabello, Juan
  • Miranda-Vizuete, Antonio
[Data availability statement] RNAseq raw data are deposited at the Sequence Read Archive of NCBI with the ID number GSE311484., Mitochondrial redox homeostasis is essential for cellular metabolism and organismal development. To investigate the consequences of disrupting redox homeostasis in this organelle in a metazoan organism, we generated a double mutant lacking mitochondrial glutathione reductase (gsr-1a) and thioredoxin reductase (trxr-2) genes in Caenorhabditis elegans. While gsr-1a or trxr-2 single mutants are phenotypically normal, double gsr-1a trxr-2 mutants displayed small body size, gonadal migration defects, reduced brood size, and prolonged egg-laying period, without developmental delay or lethality. Transcriptomic analysis revealed strong induction of ATFS-1-dependent stress and detoxification genes. Consistent with this, gsr-1a trxr-2 worms exhibited constitutive ATFS-1 nuclear localization and robust Phsp-6::gfp expression. Triple gsr-1a trxr-2; atfs-1 mutants were nonviable, demonstrating that unfolded protein response (UPRmt) activation is essential under mitochondrial redox stress., Despite the induction of a stress response at the transcriptional level, gsr-1a trxr-2 double mutants were not more resistant to oxidative or pathogen stressors. Moreover, these mutants maintained normal respiration, ATP and ROS production while displaying altered mitochondrial morphology in a tissue-specific manner, independent of mitophagy genes but dependent on mitochondrial fission or fusion machinery. Functionally, gsr-1a trxr-2 mutants showed impaired motility, reduced calcium uptake upon carbachol stimulation, enhanced hypodermal wound repair, and decreased fertilization efficiency associated with lower muscle exopher production., Overall, our data show that simultaneous loss of mitochondrial GSR-1a and TRXR-2 compromises growth, fertility and muscle performance and triggers a constitutive ATFS-1-dependent UPRmt that sustains viability revealing mitochondrial redox control as a core determinant of organismal proteostasis., Some C. elegans strains were provided by the CGC, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440) USA and by the National BioResearch Project, Japan, MVV was supported by a postdoctoral contract from the Conserjería de Universidad, Investigación e Innovación de la Junta de Andalucía, Spain (DOC_01674). PdlCR was supported by a postdoctoral contract from the Juan de la Cierva Program, Ministerio de Ciencia, Innovación y Universidades, Spain (JDC2023-051269-I). AMV lab was supported by Projects PID2021-122311NB-I00 and PID2024-155904NB-I00, JC lab was supported by Project PID2021-127388NB-I00 and JA lab was supported by Project PID2021-122239OB-I00, all financed by the Spanish Ministerio de Ciencia, Innovación y Universidades (MCIU), the Spanish Agencia Estatal de Investigación (AEI) and the Fondo Europeo de Desarrollo Regional (FEDER). JX was supported by the National Natural Science Foundation of China (Grant 32200682). NV was supported by funding from the German Research Foundation (DFG grants VE366/3-4 and VE366/12-1)., Peer reviewed